2-Bromo-5,6-dihydro-4H-pyrazolo[1,5-d][1,4]diazepin-7(8H)-one, 98%, 1g

2-(4-Chloro-2-(trifluoromethyl)phenyl)acetonitrile, 95.0%, 1g

N1,N1,N4,N4-Tetra(pyridin-4-yl)benzene-1,4-diamine, 98%, 25g

2-Chloro-6-(N-methylamino)pyrazine, 98.0%, 25g

Dimethyl-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzyl]amine, 95.0%, 250mg

3-(Aminomethyl)-4-methylbenzoic acid hydrochloride, 250mg

(6-Phenylnaphthalen-2-yl)boronic acid, 95.0%, 1g

GC capillary column ROTI®Cap-FFAP, 10 m, 0.10 mm, 0.10 µm, 1 Piece(s)

Cyclohex-3-en-1-ylmethanol, 97.00%, 10g

N-(2-Methoxyethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 1g

Phenyl carbonochloridodithioate, 95.0%, 5g

(4-(Methylsulfonyl)-2-(trifluoromethyl)phenyl)boronic acid, 95.0%, 1g

3-Bromo-5-methoxy-4-methylpyridine, 95.0%, 10g